-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 77c
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 11c
-
-
-
-
-
-
-
BrainStorm to Announce Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Tops Q3 EPS by 5c; Reports Cash and Cash Equivalents of $28M
-
1,222,673 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

